ERBB2 and intrahepatic cholangiocarcinoma: In previous studies, HER2 positivity of BTC differs according to its primary site: among BTCs, the proportion of HER2 3+ by IHC was highest in gallbladder cancer, followed by extrahepatic cholangiocarcinoma and intrahepatic cholangiocarcinoma [4, 5].